Showing all 2 results

  • Placeholder
    In Stock

    Bupropion tablets

    Free

    Product Composition & Strength

    We supply this product in three distinct Release Profiles, packed in moisture-resistant Alu-Alu or HDPE containers to protect the stability of the hydrochloride salt.

    Release ProfileStrengthPrimary Clinical Function
    Bupropion XL (Extended Release)150 mg / 300 mgThe Depression Anchor: Once-daily dosing (24-hour release) for MDD and Seasonal Affective Disorder.
    Bupropion SR (Sustained Release)150 mgThe Smoking Cessation Specialist: Twice-daily dosing (12-hour release) for smoking cessation and MDD.
    Bupropion IR (Immediate Release)75 mg / 100 mgThe Titration Unit: Immediate-release format for precise dose escalation under specialist supervision.
  • Placeholder
    In Stock

    Varenicline Tablets

    Free

    Product Composition & Strength

    We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. We specifically offer the globally mandated “Titration Starter Packs” to ensure patient compliance during the critical first two weeks of therapy.

    Active IngredientStrengthPrimary Clinical Use
    Varenicline Tartrate INN/USP0.5 mgMandatory dose-titration initiation (Days 1 through 7 of the quit attempt).
    Varenicline Tartrate INN/USP1 mgStandard Adult Maintenance Dose (Day 8 through Week 12 or 24).
    ExcipientsMicrocrystalline Cellulose / Anhydrous Dibasic Calcium Phosphate / Croscarmellose SodiumDiluent / Superdisintegrant (Ensures rapid, uniform gastric dispersion)